WADA The 2021 Monitoring Program

WADA The 2021 Monitoring Program

The following substances are placed on the 2021 Monitoring Program*:

1. Anabolic Agents:
   In and Out-of-Competition: Ecdysterone
2. Beta-2 Agonists:
   In and Out-of-Competition: Salmeterol and Vilanterol below the Minimum Reporting Level.
3. 2-ethylsulfanyl-1H-benzimidazole (bemitil):
   In and Out-of-Competition
4. Stimulants:
   In-Competition only: Bupropion, caffeine, nicotine, phenylephrine, phenylpropanolamine, pipradrol and synephrine.
5. Narcotics:
   In-Competition only: Codeine, hydrocodone and tramadol.
6. Glucocorticoids:
   In-Competition (by routes of administration other than oral, intravenous, intramuscular, or rectal) and Out-of-Competition (all routes of administration)
   
   

* The World Anti-Doping Code (Article 4.5) states: “WADA, in consultation with Signatories and governments, shall establish a monitoring program regarding substances which are not on the Prohibited List, but which WADA wishes to monitor in order to detect potential patterns of misuse in sport.”